Alfentanil potentiates anaesthetic and electroencephalographic responses to ketamine in the rat

European Journal of Pharmacology

Volumn 460, Issue 1, 2003, Pages 27-35

  Edwards, Stephen R ^a   Mather, Laurence E ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Alfentanil; Anaesthesia; Analgesia; EEG (electroencephalogram); Ketamine; Stereoisomer

Indexed keywords

ALFENTANIL; KETAMINE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INFUSION; DRUG POTENTIATION; DRUG RESPONSE; ELECTROENCEPHALOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0037466838     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02827-3     Document Type: Article

References (40)

1. Bovill J.G. Which potent opioid? Important criteria for selection. Drugs. 33:1987;520-530.
2. Chapman V., Dickenson A.H. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res. 573:1992;321-323.
3. Chen L., Huang L.M. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid. Neuron. 7:1991;319-326.
4. Church J., Lodge D. N-methyl-D-aspartate (NMDA) antagonism is central to the actions of ketamine and other phencyclidine receptor ligands. Domino E.F. Status of Ketamine in Anesthesiology. 1990;501-519 NPP Books, Ann Arbor, MI.
5. Cohen M.L., Chan S.L., Way W.L., Trevor A.J. Distribution in the brain and metabolism of ketamine in the rat after intravenous administration. Anesthesiology. 39:1973;370-376.
6. Corbett, A.D., Paterson, S.J., Kosterlitz, H.W. 1993. Selective of ligands for opioid receptors. In: Herz, A. (Ed.), Opioids I - Born, G.V.R., Cuatrecasas, P., Herken, H. (Eds.), Handbook of Experimental Pharmacology, vol. 104/1. Springer, Berlin, pp. 645-673.
7. Cox E.H., Kerbusch T., Van der Graff P.H., Danhof M. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor. J. Pharmacol. Exp. Ther. 284:1998;1095-1103.
8. Cox E.H., Kuipers J.A., Danhof M. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation. Br. J. Pharmacol. 124:1998;1534-1540.
9. Cox E.H., Langemeijer M.W.E., Danhof M. Pharmacokinetic-pharmacodynamic modeling of the analgesic effect of alfentanil in the rat using tooth pulp evoked potentials. J. Pharmacol. Toxicol. Methods. 39:1998;19-27.
10. Dimpfel W., Spuler M. Dizocilpine (MK-801), ketamine, and phencyclidine: low doses affect brain field potentials in the freely moving rat in the same way as activation of dopaminergic transmission. Psychopharmacology. 101:1990;317-323.
11. Edwards S.R., Mather L.E. Tissue uptake of ketamine and norketamine enantiomers in the rat - indirect evidence for extrahepatic metabolic inversion. Life Sci. 69:2001;2051-2066.
12. Edwards S.R., Minto C.F., Mather L.E. Concurrent ketamine and alfentanil administration: pharmacokinetic considerations. Br. J. Anaesth. 88:2002;94-100.
13. Finck A.D., Ngai S.H. Opiate receptor mediation of ketamine analgesia. Anesthesiology. 56:1982;291-297.
14. Hustveit O., Maurse A., Oye I. Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors. Pharmacol. Toxicol. 77:1995;355-359.
15. Imperato A., Scrocco M.G., Bacchi S., Angelucci L. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur. J. Pharmacol. 187:1990;555-556.
16. Irifune M., Shimizu T., Nomoto M. Ketamine-induced hyperlocommotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice. Pharmacol. Biochem. Behav. 40:1991;399-407.
17. Irifune M., Shimizu T., Nomoto M., Fukuda T. Ketamine-induced anesthesia involves the N-methyl-D-aspartate receptor-channel complex in mice. Brain Res. 596:1992;1-9.
18. Joo G., Horvath G., Klimscha W., Kekesi G., Dobos I., Szikszay M., Gyorgy B. The effects of ketamine and its enantiomers on the morphine- or dexmedetomidine-induced antinociception after intrathecal administration in rats. Anesthesiology. 93:2000;231-241.
19. Kawamata T., Omote K., Sonoda H., Kawamata M. Analgesic mechanisms of ketamine in the presence and absence of peripheral inflammation. Anesthesiology. 93:2000;520-528.
20. Kissin I., Lee S.S., Arthur R.A., Bradley E.L. Time course characteristics of acute tolerance development to continuously infused alfentanil in rats. Anesth. Analg. 83:1996;600-605.
21. Kissin I., Bright C.A., Bradley E.L. The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations. Anesth. Analg. 91:2000;1483-1488.
22. Kohrs R., Durieux M.E. Ketamine: teaching an old drug new tricks. Anesth. Analg. 87:1998;1186-1193.
23. Leung A., Wallace M.S., Ridgeway B., Yaksh T. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain. 91:2001;177-187.
24. Mandema J.W., Danhof M. EEG effect measures and relationships between pharmacokinetics and pharmacodynamics of psychotropic drugs. Clin. Pharmacokinet. 23:1992;191-215.
25. Mao J., Price D.D., Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain. 62:1995;259-274.
26. Marietta M.P., Way W.L., Castagnoli N., Trevor A.J. On the pharmacology of the ketamine enantiomorphs in the rat. J. Pharmacol. Exp. Ther. 202:1977;157-165.
27. Mather L.E., Edwards S.R., Duke C.C. Electroencephalographic effects of thiopentone and its enantiomers in the rat. Life Sci. 66:2000;105-114.
28. Mattia A., Marquis K.L., Leccese A.P., El-Fakahany E.E., Moreton J.E. Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat. J. Pharmacol. Exp. Ther. 246:1988;797-802.
29. Maurset A., Skoglund L.A., Hustveit O., Oye I. Comparison of ketamine and pethidine in experimental and postoperative pain. Pain. 1989(36):1989;37-41.
30. Nadeson R., Tucker A., Bajunaki E., Goodchild C.S. Potentiation by ketamine of fentanyl antinociception: Part I. An experimental study in rats showing that ketamine administered by non-spinal routes targets spinal cord antinociceptive systems. Br. J. Anaesth. 88:2002;685-691.
31. Ryder S., Way W.L., Trevor A.J. Comparative pharmacology of the optical isomers of ketamine in mice. Eur. J. Pharmacol. 49:1978;15-23.
32. Sagratella S., Benedetti M., Pezzola A., Carolis S. Behavioral and electroencephalographic effects of excitatory amino acid antagonists and sigma opiate/phencyclidine-like compounds in rats. Neuropharmacology. 28:1989;57-61.
33. Schmid R.L., Sandler A.N., Katz J. Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes. Pain. 82:1999;111-125.
34. Schüttler J., Stanski D.R., White P.F., Trevor A.J., Horai Y., Verotta D., Sheiner L.B. Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man. J. Pharmacokinet. Biopharm. 15:1987;241-253.
35. Sethna N.F., Liu M., Gracely R., Bennett G.J., Mitchell B. Analgesic and cognitive effects of intravenous ketamine-alfentanil combinations versus either drug alone after intradermal capsaicin in normal subjects. Anesth. Analg. 86:1998;1250-1256.
36. Shafer S.L., Gregg K.M. Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pump. J. Pharmacokin. Biopharm. 20:1992;147-169.
37. Shafer S.L., Varvel J.R. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology. 74:1991;53-63.
38. Smith D.J., Bouchal R.L., DeSanctis C.A., Monroe P.J., Amedro J.B., Perrotti J.M., Crisp T. Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro. Neuropharmacology. 26:1987;1253-1260.
39. Yamamoto T., Yaksh T.L. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci. Lett. 135:1992;67-70.
40. Yamamoto T., Shimoyama N., Mizuguchi T. The effects of morphine, MK-801, an NMDA antagonist, and CP-96, 345, an NK1 antagonist, on the hyperesthesia evoked by carageenan injection in the rat paw. Anesthesiology. 78:1993;124-133.